SCHEMBL22186384

SCHEMBL22186384

N[C@@H]1CCCN(c2ncc(Cl)cc2C(F)(F)F)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 1/20 0.44
▸ PIM1 P11309 3/20 0.44
▸ PIM2 Q9P1W9 1/20 0.43
▸ HRH4 Q9H3N8 5/20 0.43
▸ CHEK1 O14757 1/20 0.43
▸ CNR2 P34972 1/20 0.42
▸ DOT1L Q8TEK3 1/20 0.41
▸ FLT3 P36888 2/20 0.40
▸ DPP4 P27487 1/20 0.40
▸ CAMK1D Q8IU85 1/20 0.39
▸ IDH2 P48735 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ PRKCQ Q04759 2/20 0.39
▸ PRKCB P05771 1/20 0.39
▸ PRKCA P17252 1/20 0.39
▸ PRKCH P24723 1/20 0.39
▸ PRKCE Q02156 1/20 0.39
▸ PRKCD Q05655 1/20 0.39
▸ MAP4K1 Q92918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28593946 0.99 AKT1 (0.44) AKT1PIM1PIM2HRH4CHEK1
Hydrochloric Acid SCHEMBL28593943 0.99 AKT1 (0.44) AKT1PIM1PIM2HRH4CHEK1
SCHEMBL28603240 0.80 KDM4E (0.41) CHEK1CNR2
SCHEMBL28603239 0.80 KDM4E (0.41) CHEK1CNR2
SCHEMBL22186373 0.80 POLB (0.56) AKT1CNR2
SCHEMBL22186781 0.80 POLB (0.56) AKT1CNR2
Hydrochloric Acid SCHEMBL28601513 0.79 POLB (0.55) AKT1CNR2
Hydrochloric Acid SCHEMBL28597330 0.79 POLB (0.55) AKT1CNR2
Hydrochloric Acid SCHEMBL28597331 0.79 POLB (0.55) AKT1CNR2
SCHEMBL22186381 0.75 PTGS1 (0.47) PIM1PIM2HRH4DOT1LCAMK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020138271-A1 HETEROCYCLIC DERIVATIVES AS Nav1.7 and Nav1.8 BLOCKERS RAQUALIA PHARMA INC. (JP) 2020-07-02 — — WO disclosed
Send feedback